EyePoint, Inc. (EYPT) earnings
EYPT earnings moved a median of -0.24% by the close. Quarterly and annual EYPT reports and results, each read against the price at its own news timestamp. Back to the EYPT overview →
26 measured EYPT earnings events.
Where these EYPT earnings landedvs 26 measured EYPT earnings reactions
| Middle 50% of EYPT earnings reactions | -3.63% to +3.75% |
|---|---|
| Median reaction (to close) | -0.24% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 EYPT earnings events with a measured close landed between -3.63% and +3.75%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments | Press release | +0.71% | +3.11% | |
| Form 10-Q EyePoint, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.94% | +4.74% | |
| Form 10-Q EyePoint, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.31% | +2.32% | |
| EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments | Press release | -0.80% | -2.77% | |
| EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026 | Press release | -0.23% | -2.80% | |
| Form 10-K EyePoint, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.13% | +3.96% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.47% | +2.84% | |
| EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments | Press release | -8.98% | -4.22% | |
| EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | -1.49% | -5.86% | |
| Form 10-Q EyePoint Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.69% | +0.79% | |
| EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments | Press release | -1.63% | +7.74% | |
| EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | -0.98% | -3.91% | |
| Form 10-Q EyePoint Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.66% | -4.75% | |
| EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments | Press release | +0.64% | -2.56% | |
| EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025 | Press release | +0.43% | +4.28% | |
| Form 10-K EyePoint Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.73% | +4.54% | |
| EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments | Press release | -2.26% | -6.61% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.26% | +0.34% | |
| Form 10-Q EyePoint Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.22% | -2.45% | |
| EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments | Press release | -1.73% | -6.59% | |
| Form 10-Q EyePoint Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.29% | +6.61% | |
| EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments | Press release | -1.31% | -2.61% | |
| Form 10-K EyePoint Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.33% | +0.87% | |
| Form 10-Q EyePoint Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.19% | -0.83% | |
| EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments | Press release | -0.53% | +10.45% | |
| EyePoint Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 1, 2023 | Press release | -1.37% | -13.15% |
Keep exploring
More EYPT: analyst actions → · SEC filings → · EYPT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Catalyst Pharmaceuticals, Inc. (CPRX) | 441 | 0.00% | 50% |
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.